人诱导多能干细胞衍生的终末细胞类型中的小分子筛选。
Small molecule screening in human induced pluripotent stem cell-derived terminal cell types.
机构信息
From Pharmacokinetics, Dynamics and Metabolism-New Chemical Entities, Pfizer Inc., Groton, Connecticut 06340.
出版信息
J Biol Chem. 2014 Feb 21;289(8):4562-70. doi: 10.1074/jbc.R113.529156. Epub 2013 Dec 20.
Abstract
A need for better clinical outcomes has heightened interest in the use of physiologically relevant human cells in the drug discovery process. Patient-specific human induced pluripotent stem cells may offer a relevant, robust, scalable, and cost-effective model of human disease physiology. Small molecule high throughput screening in human induced pluripotent stem cell-derived cells with the intent of identifying novel therapeutic compounds is starting to influence the drug discovery process; however, the use of these cells presents many high throughput screening development challenges. This technology has the potential to transform the way drug discovery is performed.
摘要
人们对更好的临床结果的需求，使得人们对在药物发现过程中使用与生理相关的人类细胞产生了浓厚的兴趣。患者特异性的人诱导多能干细胞可能提供一种相关的、强大的、可扩展的和具有成本效益的人类疾病生理学模型。小分子高通量筛选人诱导多能干细胞衍生细胞，旨在鉴定新的治疗化合物，这开始影响药物发现过程；然而，这些细胞的使用也带来了许多高通量筛选开发的挑战。这项技术有可能改变药物发现的方式。
相似文献
1
Small molecule screening in human induced pluripotent stem cell-derived terminal cell types.人诱导多能干细胞衍生的终末细胞类型中的小分子筛选。
J Biol Chem. 2014 Feb 21;289(8):4562-70. doi: 10.1074/jbc.R113.529156. Epub 2013 Dec 20.
2
Human Induced Pluripotent Stem Cell-Derived Cardiac Progenitor Cells in Phenotypic Screening: A Transforming Growth Factor-β Type 1 Receptor Kinase Inhibitor Induces Efficient Cardiac Differentiation.表型筛选中人类诱导多能干细胞来源的心脏祖细胞：一种转化生长因子-β1受体激酶抑制剂可诱导高效的心脏分化。
Stem Cells Transl Med. 2016 Feb;5(2):164-74. doi: 10.5966/sctm.2015-0114. Epub 2015 Dec 18.
3
High-content screening of small compounds on human embryonic stem cells.高通量筛选小分子化合物对人类胚胎干细胞的影响。
Biochem Soc Trans. 2010 Aug;38(4):1046-50. doi: 10.1042/BST0381046.
4
High-throughput identification of small molecules that affect human embryonic vascular development.高通量鉴定影响人胚胎血管发育的小分子。
Proc Natl Acad Sci U S A. 2017 Apr 11;114(15):E3022-E3031. doi: 10.1073/pnas.1617451114. Epub 2017 Mar 27.
5
Human Pluripotent Stem Cells for High-Throughput Drug Screening and Characterization of Small Molecules.高通量药物筛选和小分子表征的人类多能干细胞。
Methods Mol Biol. 2022;2454:811-827. doi: 10.1007/7651_2021_394.
6
High-throughput screen for compounds that modulate neurite growth of human induced pluripotent stem cell-derived neurons.高通量筛选化合物，调节人诱导多能干细胞源性神经元的神经突生长。
Dis Model Mech. 2018 Feb 2;11(2):dmm031906. doi: 10.1242/dmm.031906.
7
Induced pluripotent stem cells: opportunities as research and development tools in 21st century drug discovery.诱导多能干细胞：21 世纪药物发现中作为研究和开发工具的机遇。
Regen Med. 2010 Jul;5(4):557-68. doi: 10.2217/rme.10.36.
8
A high-throughput screen for Wnt/β-catenin signaling pathway modulators in human iPSC-derived neural progenitors.在人诱导多能干细胞衍生的神经祖细胞中对Wnt/β-连环蛋白信号通路调节剂进行高通量筛选。
J Biomol Screen. 2012 Oct;17(9):1252-63. doi: 10.1177/1087057112456876. Epub 2012 Aug 24.
9
A small-molecule screen reveals that HSP90β promotes the conversion of induced pluripotent stem cell-derived endoderm to a hepatic fate and regulates HNF4A turnover.一项小分子筛选显示，热休克蛋白90β（HSP90β）可促进诱导多能干细胞来源的内胚层向肝细胞命运的转变，并调节肝细胞核因子4A（HNF4A）的周转。
Development. 2017 May 15;144(10):1764-1774. doi: 10.1242/dev.146845. Epub 2017 Mar 30.
10
High-Throughput Phenotypic Screening of Human Astrocytes to Identify Compounds That Protect Against Oxidative Stress.对人星形胶质细胞进行高通量表型筛选以鉴定抗氧化应激化合物
Stem Cells Transl Med. 2016 May;5(5):613-27. doi: 10.5966/sctm.2015-0170. Epub 2016 Mar 31.
引用本文的文献
1
In silico modeling of directed differentiation of induced pluripotent stem cells to definitive endoderm.诱导多能干细胞定向分化为确定内胚层的计算机模拟建模
PLoS Comput Biol. 2025 Aug 21;21(8):e1013407. doi: 10.1371/journal.pcbi.1013407. eCollection 2025 Aug.
2
Advances in Genetic Reprogramming: Prospects from Developmental Biology to Regenerative Medicine.遗传重编程的进展：从发育生物学到再生医学的前景。
Curr Med Chem. 2024;31(13):1646-1690. doi: 10.2174/0929867330666230503144619.
3
Inducible Pluripotent Stem Cells to Model and Treat Inherited Degenerative Diseases of the Outer Retina: 3D-Organoids Limitations and Bioengineering Solutions.诱导多能干细胞模型与治疗外视网膜遗传性退行性疾病：3D 类器官的局限性与生物工程解决方案。
Cells. 2021 Sep 20;10(9):2489. doi: 10.3390/cells10092489.
4
Autophagy and ALS: mechanistic insights and therapeutic implications.自噬与肌萎缩侧索硬化症：机制见解与治疗意义。
Autophagy. 2022 Feb;18(2):254-282. doi: 10.1080/15548627.2021.1926656. Epub 2021 May 31.
5
450s nder striction (PURE) Screen Using HepaRG and Primary Human Hepatocytes for Discovery of Novel HBV Antivirals.使用HepaRG细胞和原代人肝细胞进行新型HBV抗病毒药物发现的450s限制（PURE）筛选
ACS Med Chem Lett. 2020 Feb 26;11(10):1919-1927. doi: 10.1021/acsmedchemlett.9b00630. eCollection 2020 Oct 8.
6
Unprecedented Potential for Neural Drug Discovery Based on Self-Organizing hiPSC Platforms.基于自组织 hiPSC 平台的神经药物发现具有前所未有的潜力。
Molecules. 2020 Mar 4;25(5):1150. doi: 10.3390/molecules25051150.
7
Recent policies that support clinical application of induced pluripotent stem cell-based regenerative therapies.支持基于诱导多能干细胞的再生疗法临床应用的近期政策。
Regen Ther. 2016 Mar 1;4:36-47. doi: 10.1016/j.reth.2016.01.009. eCollection 2016 Jun.
8
New Drug Discovery Paradigms for Retinal Diseases: A Focus on Retinal Organoids.用于视网膜疾病的新药发现范式：以视网膜类器官为重点。
J Ocul Pharmacol Ther. 2020 Jan/Feb;36(1):18-24. doi: 10.1089/jop.2018.0140. Epub 2019 May 6.
9
Glycolytic Switch Is Required for Transdifferentiation to Endothelial Lineage.糖酵解开关对于向血管内皮谱系的转分化是必需的。
Circulation. 2019 Jan 2;139(1):119-133. doi: 10.1161/CIRCULATIONAHA.118.035741.
10
Modeling Hematological Diseases and Cancer With Patient-Specific Induced Pluripotent Stem Cells.利用患者特异性诱导多能干细胞进行血液疾病和癌症建模。
Front Immunol. 2018 Sep 28;9:2243. doi: 10.3389/fimmu.2018.02243. eCollection 2018.
本文引用的文献
1
Stepwise, non-adherent differentiation of human pluripotent stem cells to generate basal forebrain cholinergic neurons via hedgehog signaling.通过刺猬信号通路将人多能干细胞逐步、非贴壁分化以生成基底前脑胆碱能神经元。
Stem Cell Res. 2013 Nov;11(3):1206-21. doi: 10.1016/j.scr.2013.08.002. Epub 2013 Aug 9.
2
Generation of mouse induced pluripotent stem cells by protein transduction.通过蛋白转导生成小鼠诱导多能干细胞。
Tissue Eng Part C Methods. 2014 May;20(5):383-92. doi: 10.1089/ten.TEC.2013.0026. Epub 2013 Oct 12.
3
Scalable expansion of human induced pluripotent stem cells in the defined xeno-free E8 medium under adherent and suspension culture conditions.在无动物源的E8限定培养基中，于贴壁和悬浮培养条件下对人诱导多能干细胞进行可扩展的扩增。
Stem Cell Res. 2013 Nov;11(3):1103-16. doi: 10.1016/j.scr.2013.07.011. Epub 2013 Aug 9.
4
Highly efficient induction and long-term maintenance of multipotent cardiovascular progenitors from human pluripotent stem cells under defined conditions.在定义条件下，从人多能干细胞中高效诱导和长期维持多能心血管祖细胞。
Cell Res. 2013 Sep;23(9):1119-32. doi: 10.1038/cr.2013.102. Epub 2013 Jul 30.
5
Endothelial progenitor cells from human dental pulp-derived iPS cells as a therapeutic target for ischemic vascular diseases.人牙髓诱导多能干细胞来源的内皮祖细胞作为缺血性血管疾病的治疗靶点。
Biomaterials. 2013 Nov;34(33):8149-60. doi: 10.1016/j.biomaterials.2013.07.001. Epub 2013 Jul 26.
6
A cellular model for sporadic ALS using patient-derived induced pluripotent stem cells.利用患者来源的诱导多能干细胞建立散发性肌萎缩侧索硬化症的细胞模型。
Mol Cell Neurosci. 2013 Sep;56:355-64. doi: 10.1016/j.mcn.2013.07.007. Epub 2013 Jul 25.
7
Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds.小分子化合物诱导的小鼠体细胞多能干细胞。
Science. 2013 Aug 9;341(6146):651-4. doi: 10.1126/science.1239278. Epub 2013 Jul 18.
8
Validating therapeutic targets through human genetics.通过人类遗传学验证治疗靶点。
Nat Rev Drug Discov. 2013 Aug;12(8):581-94. doi: 10.1038/nrd4051. Epub 2013 Jul 19.
9
Generation of functionally competent and durable engineered blood vessels from human induced pluripotent stem cells.从人诱导多能干细胞生成功能完备且持久的工程化血管。
Proc Natl Acad Sci U S A. 2013 Jul 30;110(31):12774-9. doi: 10.1073/pnas.1310675110. Epub 2013 Jul 16.
10
Phenotypic screens as a renewed approach for drug discovery.表型筛选作为药物发现的一种新方法。
Drug Discov Today. 2013 Nov;18(21-22):1067-73. doi: 10.1016/j.drudis.2013.07.001. Epub 2013 Jul 9.
Zotero 插件